Tracked shipping to the Netherlands for just € 7. Prices include 9% BTW and new EU € 3 customs duty. No hidden fees. 

Ship to
Netherlands
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis
Type
Physical Book
Author
Publisher
Language
English
Pages
34
Format
Paperback
Dimensions
25.4 x 17.8 x 0.2 cm
Weight
0.08 kg.
ISBN13
9781727250930
Categories

Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis

The Law Library (Author) · Createspace · Paperback

Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis - The Law Library

New Book Imported to Netherlands
Delivery: 13 Aug - 20 Aug Shipping: 16 to 20 business days.
30,01 €
Import costs and 9% BTW included in the price ✅
30,01 €

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis"

Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Administration Regulation) (FDA) (2018 Edition) The Law Library presents the complete text of the Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Administration Regulation) (FDA) (2018 Edition). Updated as of May 29, 2018 The Food and Drug Administration (FDA or the Agency) is issuing an interim final rule amending its postmarketing reporting regulations implementing certain provisions of the Federal Food, Drug and Cosmetic Act. The provisions of the Federal Food, Drug and Cosmetic Act require manufacturers who are the sole manufacturers of certain drug products to notify FDA at least 6 months before discontinuance of manufacture of the products. This interim final rule modifies the term "discontinuance" and clarifies the term "sole manufacturer" with respect to notification of discontinuance requirements. The broader reporting resulting from these changes will enable FDA to improve its collection and distribution of drug shortage information to physician and patient organizations and to work with manufacturers and other stakeholders to respond to potential drug shortages. This book contains: - The complete text of the Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Administration Regulation) (FDA) (2018 Edition) - A table of contents with the page number of each section

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews